Bandingkan Harga & Kinerja Teladan Prima Agro Tbk. (TLDN) vs Tempo Scan Pacific Tbk. (TSPC)
Kinerja harga (24 Jam Terakhir)
Statistik utama
Statistik utama
Perbedaan Teladan Prima Agro Tbk. dan Tempo Scan Pacific Tbk.: Teladan Prima Agro Tbk. diperdagangkan di Rp550 (kapitalisasi pasar 7,31 T, volume 24 jam 1,01 jt), sedangkan Tempo Scan Pacific Tbk. diperdagangkan di Rp2.780 (kapitalisasi pasar 12,58 T, volume 24 jam 218,4 rb). Perbedaan utamanya: Tempo Scan Pacific Tbk. lebih besar dari sisi kapitalisasi pasar, dan Teladan Prima Agro Tbk. lebih aktif diperdagangkan (1,01 jt vs 218,4 rb). Mana yang lebih baik tergantung tujuan investasimu.
| TLDN | TSPC | |
|---|---|---|
Kapitalisasi Pasar | 7,31 T | 12,58 T |
Volume | 1,01 jt | 218,4 rb |
Lot | 10,09 rb | 2,18 rb |
Perputaran | 556,81 jt | 603,17 jt |
Harga Rata-rata | 551,9 | 2.761,75 |
Nilai Transaksi | 556,81 jt | 603,17 jt |
Harga Ekuilibrium Indikatif | 565 | 2.790 |
Volume Ekuilibrium Indikatif | 3,3 rb | 3,9 rb |
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Berita terkini
Berita terbaru kedua aset
Berita terkini
Berita terbaru kedua aset
Tentang Teladan Prima Agro Tbk.
PT Teladan Prima Agro Tbk ( formerly PT Sandaran Prima Sawit ) was established in the Republic of Indonesia on May 10, 2004 based on the Notarial Deed No. 22 of Imas Fatimah, S.H. On May 25, 2012, the Company's shareholders approved the proposed merger with PT Teladan Agro Resources (“TAR”) where the Company is the recipient of the merger (“Penggabungan 2012”).
Selengkapnya di halaman TLDN →Tentang Tempo Scan Pacific Tbk.
PT. Tempo Scan Pacific Tbk (the Company) was established in the Republic of Indonesia dated 20 May 1970, under its original name PT Scanchemie within the framework of the Domestic Capital Investment Law No. 6 year 1968, as amended by Law No. 12 year 1970, based on Notarial Deed No. 37 of Ridwan Suselo, S.H. The company is famous for such pharmaceutical products as Bodrex, Hemaviton and Neo-Rheumacyl.
Selengkapnya di halaman TSPC →
